Cleared Traditional

K163485 - SmartTouch

K163485 is an FDA 510(k) clearance for SmartTouch, manufactured by Adherium (Nz), Ltd.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K163485 · Adherium (Nz), Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
261d
Days
Class 2
Risk

K163485 is an FDA 510(k) clearance for the SmartTouch. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Adherium (Nz), Ltd. (Auckland, NZ). The FDA issued a Cleared decision on August 30, 2017 after a review of 261 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Adherium (Nz), Ltd. devices

FDA 510(k) Submission Details - K163485

510(k) Number K163485 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2016
Decision Date August 30, 2017
Days to Decision 261 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 140d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 409
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K163485.
Portable Nebulizer
K170916 · Microbase Technology Corporation · Nov 2017
InnoSpire Go
K170853 · Respironics Respiratory Drug Delivery (Uk) , Ltd. · Nov 2017
The JLN-23XX Series Piston Compress Nebulizer (with models JLN-2300AS, JLN-2301AS, JLN-2317AS and JLN-2320AS)
K161586 · Shenzhen Homed Medical Device Co., Ltd. · Sep 2017
AirLife Misty Finity Nebulizer
K153748 · Care Fusion · May 2017
Airworks Nebulizer pe1200m
K162041 · Convexity Scientific, LLC · May 2017
Velox Nebulizer System
K162785 · Pari Respiratory Equipment, Inc. · Apr 2017